Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Beuers

Showing results (181-190 of 298) with videos related to

Pageof 30
Sort By:
JHEP Reports : Innovation in Hepatology|July 10, 2020
IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancerElsemieke de Vries, Floor Tielbeke, Lowiek Hubers, et al.
Digestive Diseases (Basel, Switzerland)|July 19, 2014
IgG4-associated cholangitisUlrich Beuers, Lucas J Maillette de Buy Wenniger, Marieke Doorenspleet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2020
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinomaElsemieke de Vries, Marta Mazzetti, Bart Takkenberg, et al.
Annals of Hepatology|March 9, 2024
Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosisKoos de Wit, Diederick J van Doorn, Bregje Mol, et al.
Journal of Hepatology|August 20, 2023
IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathiesRemco Kersten, David C Trampert, Toni Herta, et al.
Hepatology (Baltimore, Md.)|November 2, 2010
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liverGerald U Denk, Silvia Maitz, Ralf Wimmer, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in miceRoni F Kunst, Isabelle Bolt, Rychon D J van Dasselaar, et al.
Biochimica Et Biophysica Acta|May 2, 2012
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemiaPaula S Montenegro-Miranda, Nina Sneitz, D Rudi de Waart, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 8, 2025
The role of bile salts in itch receptor activationFrank Wolters, Dagmar Tolenaars, Michel van Weeghel, et al.
Scientific Reports|May 12, 2017
Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivoRemco van Dijk, Sem J Aronson, Dirk R de Waart, et al.
Pageof 30

Showing results (181-190 of 298) with videos related to

Sort By:
Pageof 30
JHEP Reports : Innovation in Hepatology|July 10, 2020
IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancerElsemieke de Vries, Floor Tielbeke, Lowiek Hubers, et al.
Digestive Diseases (Basel, Switzerland)|July 19, 2014
IgG4-associated cholangitisUlrich Beuers, Lucas J Maillette de Buy Wenniger, Marieke Doorenspleet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2020
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinomaElsemieke de Vries, Marta Mazzetti, Bart Takkenberg, et al.
Annals of Hepatology|March 9, 2024
Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosisKoos de Wit, Diederick J van Doorn, Bregje Mol, et al.
Journal of Hepatology|August 20, 2023
IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathiesRemco Kersten, David C Trampert, Toni Herta, et al.
Hepatology (Baltimore, Md.)|November 2, 2010
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liverGerald U Denk, Silvia Maitz, Ralf Wimmer, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in miceRoni F Kunst, Isabelle Bolt, Rychon D J van Dasselaar, et al.
Biochimica Et Biophysica Acta|May 2, 2012
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemiaPaula S Montenegro-Miranda, Nina Sneitz, D Rudi de Waart, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 8, 2025
The role of bile salts in itch receptor activationFrank Wolters, Dagmar Tolenaars, Michel van Weeghel, et al.
Scientific Reports|May 12, 2017
Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivoRemco van Dijk, Sem J Aronson, Dirk R de Waart, et al.
Pageof 30